Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066690
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-02
First Post:
2003-08-06
Brief Title:
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IIIA Breast Cancer |
| Estrogen Receptor Positive Breast Cancer |
| Progesterone Receptor Positive Tumor |
| Recurrent Breast Carcinoma |
| Stage IA Breast Cancer |
| Stage IB Breast Cancer |
| Stage IIA Breast Cancer |
| Stage IIB Breast Cancer |